James M Frates

Chief Financial Officer, Amylyx Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.6M

Companies

Latest trade

Sep 10, 2026

Companies

Amylyx Pharmaceuticals, Inc.Chief Financial Officer −$0.7M

Trades

AMLX Sold 10,810 shares at $32.36 $0.3M Sep 10

AMLX Sold 7,909 shares at $14.52 $0.1M Mar 2

AMLX Sold 3,557 shares at $14.65 $0.1M Feb 2

AMLX Sold 3,326 shares at $11.11 $0.0M Jan 6

AMLX Sold 10,558 shares at $14.65 $0.2M Sep 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.